well welcome this is just a brief talk
on
adverse events after vaccination now of
course after vaccination it's quite
relatively normal to get a few minor
side effects but uh
in a vast minority a tiny minority of
cases
there are more severe complications and
the important thing is to know what
these are and to look out for them
so let's just have a look at this report
here
this is from the this is published on
the 17th of may from the
centers for disease control
and this one is particularly about
adverse events
after the messenger rna vaccines
so the messenger rna vaccines of course
in the states are the pfizer and the
modern vaccines
as opposed to the uh adenovirus of
vector vaccines
which are the janssen johnson johnson
vaccine and the oxford astra
zenica vaccine so let's start off with
what this report tells us now this
report is
interesting but very light it has to be
said on
numbers so it describes things but
doesn't really give a lot of numbers now
hopefully these will be coming out
soon but we'll give some numbers some
other data that will give us some
indication
of what might be coming out in the
states
based on what happened in israel not
that we know that yet but it would be
good to get the numbers
soon now myocarditis after the mr
messenger rna ribonucleic acid vaccines
now um you probably know if you've
watched previous videos or from general
knowledge the myocardium is the
contractile muscle in the heart
myocarditis anything that endonitis
inflammation
of so there's inflammation of the
myocardium
and this can happen uh 12 to about
four days after the vaccine seems to be
the kind of time
it possibly could occur based on the
israeli data anyway
but let's come up to date with the uh
the u.s data here
so this this is report from the advisor
committee on immunization
practice vaccine safety technical
working group
um their various groupings are in the
states
but the report particularly on the uh
the vaccine
safety technical working group here so
this is their report from the um
from the 17th of may now what they say
here is
uh they've included several
presentations on myocarditis following
messenger rna vaccines
so they do seem to be saying here that
this is a
potential adverse effect this is the
first time this seems to have been sort
of
admitted to now the numbers are very low
um is it something to worry about it's
well it's certainly something to take
into account yes
it's being aware of these things and
treating the patients early
in the same way that there was this
blood clot problem with the oxford
astrozenica vaccine now people
know how to treat it as susan was
talking about in the last video
it is less of a life-threatening risk
now but always very small
numbers so they received reports from
the
department of defense in the states
vaccine adverse
events reporting system vaccine safety
data link veterans administration
clinical immunization safety assessment
groups so all of these groupings
reported
and from what it says it looks like
they've reported some cases of
post-vaccine myocarditis
after the pfizer in modern vaccines
after the messenger
rna vaccines
um so they put this positively they put
vast
uh so the fact that what's the vast one
that's the that's the vaccine safety
technical
working group concluded that there are
relatively few reports of myocarditis so
this is
true but they do seem to be
acknowledging that there
are now some now
part of the reason i wanted to do this
video was that a lot of the focus in the
press
seems to have been on complications of
the um
the adenovirus vector vaccines the
oxford estrogenic vaccine and the
janssen johnson johnson vaccine whereas
just wanted to balance things out a bit
but there's an important point that i'm
going to have to come to that i can't
rush but anyway
cases seem to occur so basically there
is
uh four four things cases seem to occur
so
um most of the cases predominantly in
adolescents and young adults
so it seems to be younger people that
are more prone to getting this
myocarditis
after the mrna vaccines often more males
than females
so young adults often males
more often following the second than the
first dose
so after the first dose it doesn't seem
to be such a problem
um after the second dose it is more of a
problem
some data has shown that if people get
this condition after the first dose
it's because they previously had the
actual virus
so this seems to be some interaction
between the vaccine and the immune
response the body's already
generated from that data typically
within four days
after vaccination uh 12
12 12 hours to four days so that's
roughly consistent with the israeli data
actually
the israeli data said 12 to 96 hours
from memory
they're they're the four groupings
so um after the second dose typically
unless someone's had the infection
typically four days within four days
after the vaccination
most cases appear to be mild which is
encouraging but they are
following up now i think there's a
really important
immediate implication here so that the
the main feature of this would likely be
chest pain so chest pain needs to be
taken seriously and needs to be assessed
and i think it's generally well
obviously if you had myocarditis
exercise would be absolutely
contraindicated because
that means you would never do it because
if the heart muscle was inflamed
and you start exercising because the
muscle's inflamed the electrical
activity in the heart muscle may be
abnormal
and that could mean that the heart
muscle does that which is called
ventricular fibrillation
i don't there's any cases of that
happening but i think that's why it's
important
not to exercise um after vaccine for for
a period of time or not do strenuous
exercise anyway
if that can be avoided for a period of
time and certainly if there's any
adverse effects such as chest pain
after a vaccine although they're very
unlikely to occur if there was those
effects then
people should rest until their senior
doctors tell them otherwise
so um interesting now the thing is this
has got implications for the uk
so from the 7th of may the uk
under 40 is to be offered alternative
vaccine to the astrazeneca
and of course in in the uk that means
it's an mrna vaccine
uh the pfizer or the moderna vaccine
so under 40s basically need to be
offered an alternative vaccine
and that means it's an mrna vaccine
so in the uk we're saying offer these
mrna vaccines
rather than the adenovirus oxford
astrozenica vaccine
to younger people prefer the mrna
vaccines
it's basically what we seem to be saying
in the uk
but let's go back and look at the data
from the us
predominantly in adolescents and young
people
got the com this complication after the
mrna vaccines
and yet in the uk we are advocating
these vaccines for the younger people
rather than the adenovirus vectors
often more in males rather than females
well
half about half the population under the
age of 40 in the uk is male
so what i think
the vaccination authorities need to do
in the uk
and the u.s is tell us whether
young men might be better off avoiding
the mrm rna vaccines so that's the
question i'm asking i'm i'm not saying
that i think they should adjudicate on
that
so at the moment they're saying
offer an alternative vaccine to anyone
under the age of 40. that includes young
men
that means they're more likely to get
the mrna vaccine but we know
that there's an increased risk of
myocarditis
albeit it's very small but of course the
risk that they're trying to guard
against which is the thromboembolic
complications
and the thrombocytopenia are very rare
in the adenovirus oxford astrazeneca and
and um janssen johnson johnson vaccine
and the the risks of the
thrombocytopenia thrombosis syndrome
are greater in women so i'm just
wondering
i i think the vaccine agencies should
state
if they would prefer young men to have
the oxford astrazeneca type vaccine in
the uk
whereas young women would probably be
better off getting the pfizer vaccine
because it's more males than females get
the
myocarditis after the mrna vaccines and
it's more females than males
get the thrombocytopenia thrombosis
syndrome after the adenovirus vector
vaccines
so i wonder if they'd like to make an
announcement on that
i may be completely wrong i don't have
the full data they do
but from what i'm seeing here from what
i'm seeing here
it could be that they decide in time
to offer young men
the uh adenovirus vector vaccines
and young women the mrna vaccines
but so far there's no mention of that
and i must say i do find
this i find this surprising that they've
just done a blanket thing based on age
but they seem to ignore the sex
difference
data
young men more often now
in the same um actually it's further
down
this is a link here that this link is
actually on this
page here this link here is um
there's that link there so
we could maybe just go into that so
that this is the information uh here
on that one now um let me summarize what
that is saying as well
so this is the thrombosis
thrombocytopenia syndrome
which i think we're probably familiar
with the blood clots and the low
platelets
following the janssen vaccine in reports
in the states
now it's a little difficult to follow
this to be quite honest
um so they give lots of information here
and let me just show you where i got my
figures from this is like in the form of
a powerpoint which is a
i guess it's just the way they're
presenting the the data in this
situation
but the the way i got these figures were
from here
so that these figures here on on the
vaccination numbers
before the pause and after the pause for
the um
for the for the uh janssen johnson
johnson vaccine in the states
anyway here's the data so i've
calculated from that that it's
this is information from 7.4 million
doses of the
janssen vaccine um
now the the this
tsa tts the thrombose thrombosis
thrombocytopenia syndrome this blood
rare blood clot disease
median age of complication was 40
patients aged in range from 18 to 59
and as far as i can tell from the 7.4
million cases
7.4 million doses rather of the yanson
vaccine given there was 28 cases of
thrombocytopenic thrombosis syndrome
identified
22 female 6 male so we see
that more females
are getting complication from the uh
from the adenovirus vector vaccines
more males are getting complications
from the messenger
rna vaccines particularly in the younger
age groups
so it's always the younger age groups
that are more affected
but the mrna vaccines are affecting more
young men
the adenovirus vector vaccines are
affecting more young women
that's why it would make sense to me
that
the authorities adjudicate on that so
advising that young women get the fires
are modern or young men get the um
the yanson or the oxford astrozenica i
don't know but i think that's
i would like to hear them make a
declaration on that i really think that
they should rather than just the simple
sex differential now just to compare
these numbers so
that that was 28 cases out of 7.4
million
vaccines now frustratingly
um this site here where they're
reporting on this
um they haven't yet as far as i can see
published any numbers now i wonder why
they haven't
published any numbers on this because
the published numbers on the
janssen vaccine
if i've just missed it email it to me
send it to me but
so 7.4 million doses 28 cases of
thrombocytopenia thrombosis syndrome
now given that we haven't got data from
the united states on the
incidence of myocarditis after
mrna vaccines for example pfizer is an
mrna vaccine
let's look at israeli data and we looked
at this a few weeks ago
now in in israel they looked at five
million people that were fully
vaccinated that had had two doses that
is
and they recorded 62 cases of
viral myocarditis
mostly after the uh mostly after the
second dose most in men
under 30. so again
mostly in young men so the the fact that
this data is consistent with the united
states
makes me think this is probably correct
so again my question is
would it be better to give young men the
oxford astrazeneca
or the janssen johnson johnson vaccine
rather than the fisa vaccine
it's uh it's it's a question they don't
seem to be uh considering
but if we look at that so that was 5
million out of 62.
so that was 5 million 62 cases
of myocarditis after 5 million
vaccinations
whereas this was 28 cases after 7.4
million vaccinations
now i haven't i haven't worked out the
uh the the figures here
but you can see that 28 out of 74 so you
can see actually
this is a higher percentage isn't it
work out the percentage if you want
but uh 28 out of 7.4 million
versus 62 out of 5 million this is a
higher percentage
so it looks like it looks like from this
there's potentially more myocarditis
after the
mrna vaccines as opposed to the one that
the media and people seem to have
been subject to a lot of publicity from
for the uh for the adenovirus vector
vaccines
and yet from the israeli data here this
seems to be a greater risk after the
mrna vaccines
so um the
the the people that are this is
recognized early in and they're properly
treated
then um we couldn't expect them to do
well
but that they're also very rare
you know that but this is still not uh
any reason
all of the regulatory authorities say
you're safer to get the vaccine than not
so it's not this is not anti-vaccine in
any way
but it is indicating to me
that i want the regulatory authorities
to declare
the sexual difference in young people as
i've said
because it would seem to me from the
data that we have that relatively
speaking
it would be safer for young men to get
the oxford astrazeneca
or the yanson and young women to get the
fisa or the moderna
let's hope there's some declaration on
that
rather than this rather crude
uh just everyone under a particular age
rather than mentioning uh gender so
i've made appeals to regulatory
authorities uh
many times don't think they've ever
listened once but um
we have actually been anticipated a few
issues on the on this channel quite a
few issues
including the whole pandemic itself back
in january 2020 so
it would be good if that was addressed
so we could choose which vaccine we are
using to minimize
the already very very small risks of
adverse reactions but to
minimize them as much as possible and it
looks like
sex differentiation is going to be
necessary to do that
let's hope the regulatory authorities
make a pronouncement on this soon
even if it's to say there's no
difference forget it but at least i've
said that officially
but from the data we have that's how i
read it
at the moment so thank you for watching
this video